Items Tagged ‘#diffuse large B cell lymphoma’

March 27, 2018

Putting the precision in precision medicine care for non-Hodgkin’s lymphoma

By Sharon Rosen Sharon Rosen (@sharonhrosen)

Each year, more than 20,000 people in the U.S. are diagnosed with diffuse large B-cell lymphoma, the most common type of non-Hodgkin’s lymphoma. While the likelihood of developing the disease increases with age, men and women in all age groups and from many ethnic backgrounds can develop the disease, which can start in many areas of […]

View full entry

Tags: #blood test, #diffuse large B cell lymphoma, #Dr. Grzegorz Nowakowski, #Dr. Lisa Rimsza, #medical reearch, #Molecular Diagnostic Arizona Laboratory, #non-Hodgkin's lymphoma, center for individualized medicine, DNA, DNA Sequencing, genetic test, Genetics


December 21, 2016

Mayo Clinic first in U.S. to offer lymphoma genomic diagnostic test for patients

By Sharon Rosen Sharon Rosen (@sharonhrosen)

Article by Colette Gallagher, Public Affairs More than 20,000 people in the U.S. are diagnosed with diffuse large B-cell lymphoma, the most common type of non-Hodgkin’s lymphoma each year. Mayo Clinic is the first site in the country to offer a genetic test to help guide diagnosis and treatment of patients with diffuse large B-cell […]

View full entry

Tags: #diffuse large B cell lymphoma, #Lymph2Cx test, #Mayo Clinic Molecular Diagnostic Arizona Laboratory, #non-Hodgkin's lymphoma, center for individualized medicine, lymphoma, mayo clinic, medical research, Precision Medicine


Contact Us · Privacy Policy